| 000 | 01685nam a2200433Ka 4500 | ||
|---|---|---|---|
| 001 | ocn844975955 | ||
| 003 | OCoLC | ||
| 005 | 20221128212257.0 | ||
| 006 | m d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130529s2012 nyu ob 001 0 eng d | ||
| 040 |
_aN$T _cN$T |
||
| 020 | _a9781620818268 (electronic bk.) | ||
| 020 | _a1620818264 (electronic bk.) | ||
| 020 | _z9781620818138 | ||
| 020 | _z1620818132 | ||
| 035 | _a(OCoLC)844975955 | ||
| 035 |
_a581786 _b(N$T) |
||
| 072 | 7 |
_aMED _x093000 _2bisacsh |
|
| 072 | 7 |
_aMED _x105020 _2bisacsh |
|
| 049 | _aN$TA | ||
| 245 | 0 | 0 |
_aSynthetic drugs _h[electronic resource] : _bscope and trends in synthetic cannabinoids and stimulants _c |
| 260 |
_aHauppauge, N.Y. : _bNova Science ; _aLancaster : _bGazelle [distributor], _c2012. |
||
| 300 |
_a1 online resource (xi, 122 p.) : _bill. |
||
| 490 | 1 | _aSubstance abuse assessment, interventions and treatment | |
| 490 | 1 | _aDrug transit and distribution, interception and control | |
| 504 | _aIncludes bibliographical references and index. | ||
| 588 | _aDescription based on print version record. | ||
| 650 | 0 | _aDesigner drugs. | |
| 700 | 1 | _aGray, Terrence L. | |
| 700 | 1 | _aEvans, Sage F. | |
| 830 | 0 | _aSubstance abuse assessment, interventions and treatment. | |
| 830 | 0 | _aDrug transit and distribution, interception and control. | |
| 856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=581786 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 938 |
_aEBSCOhost _bEBSC _n581786 |
||
| 910 | _acpp1723AUTO | ||
| 942 | _n0 | ||
| 994 |
_a02 _bN$T |
||
| 999 |
_c91203 _d91203 |
||